Zonisamide is a medicine used to help control seizures. It's often taken along with other seizure medications. It works by blocking certain electrical signals in the brain that can cause seizures.
Every report comes from a Lived member, sent anonymously.
Have you tried Zonisamide for Epilepsy?
Zonisamide is an anti-seizure medicine (also called an anticonvulsant or antiepileptic drug) sold as generic capsules, under the brand name Zonegran, and as a liquid suspension called Zonisade. In the US it is approved as an add-on treatment for partial-onset seizures, also called focal seizures, which start in one area of the brain. Zonegran is approved for adults; Zonisade is approved for adults and teenagers 16 and older. Add-on means zonisamide is taken alongside one or more other seizure medicines when those have not controlled seizures well enough on their own. It has been studied as a sole treatment, but that is not an approved use in the US, and its safety and effectiveness in children under 16 have not been established. In clinical trials of people whose focal seizures continued despite other medicines, adding zonisamide made it nearly twice as likely that seizure frequency fell by at least half, compared with adding a placebo. Put another way, about one extra person in every six treated had that level of improvement.
A seizure happens when a group of nerve cells in the brain starts firing in an abnormal, synchronized burst. Nerve cells fire by letting charged particles flow through tiny channels in their outer membrane. Zonisamide appears to block two of these channel types, sodium channels and a kind of calcium channel, which steadies the cells and makes it harder for a seizure burst to start and spread. Researchers do not know the exact mechanism, and these laboratory findings do not fully explain its effect in people. Zonisamide also blocks an enzyme called carbonic anhydrase. One of this enzyme's jobs is helping the kidneys hold on to bicarbonate, the body's main buffer against acid. Losing more bicarbonate in the urine explains two of zonisamide's distinctive side effects: a mild acid build-up in the blood and a higher chance of kidney stones. Zonisamide stays in the body for a long time; about half a dose is still present roughly two and a half days after it is taken. That is why it can be taken once a day, and why each dose change takes about two weeks to settle into a steady level.
Zonisamide is taken by mouth once or twice a day, with or without food. Capsules come in 25 mg and 100 mg strengths and should be swallowed whole. The Zonisade liquid needs to be shaken well before each dose and measured with the device the pharmacy provides, not a kitchen spoon; an opened bottle is thrown away after 30 days. Treatment starts at a low dose that is raised in steps, usually no faster than every two weeks because of how slowly the drug builds up. Many people take between 100 and 400 mg a day. The original trials found no added benefit above 400 mg a day, and side effects become more frequent at 300 mg a day and above. People with kidney or liver disease may need slower increases and closer checks, and zonisamide is generally not used when kidney function is significantly reduced. Drinking plenty of fluids through the day may lower the risk of kidney stones. Do not stop zonisamide suddenly: stopping abruptly can bring on more frequent seizures or a prolonged, dangerous seizure (status epilepticus). When it needs to stop, the prescriber lowers the dose gradually.
The most common side effects are sleepiness, loss of appetite, dizziness, unsteadiness when walking, irritability and trouble with memory or concentration. Nausea, headache, double vision and weight loss also occur. Many of these are tied to dose and appear in the first month, and some people find their thinking feels slower or they have trouble finding words, particularly above 300 mg a day. Until you know how zonisamide affects you, take care with driving or other tasks that need full alertness. Zonisamide can cause or worsen depression, and less often psychotic symptoms such as hallucinations or losing touch with reality; these deserve a prompt call to the prescriber. About 4 percent of adults in the clinical trials developed kidney stones. Sudden back or side pain, abdominal pain or blood in the urine should be reported right away. The acid build-up described above is often silent and found on a blood test, but fast breathing, unusual tiredness, poor appetite or an irregular heartbeat can be signs of it and should also be reported promptly. Zonisamide can reduce sweating, which can lead to overheating or heat stroke. Children are at greatest risk, especially in hot weather, so a child who is not sweating as usual or who runs a high temperature needs a call to the prescriber right away. Some rare reactions are serious because zonisamide is a sulfonamide, the same chemical family as sulfa drugs: Rash. Any new rash should be reported to the prescriber right away. Rarely, zonisamide causes severe, sometimes fatal skin reactions, usually in the first weeks or months of treatment. Body-wide allergic reaction. Fever, swollen glands or facial swelling, with or without a rash, need to be evaluated by a clinician the same day. Blood problems. Fever, sore throat, mouth sores or easy bruising can signal a drop in blood cells and should be reported right away. Eye problems. Sudden blurred vision or eye pain, usually within the first month, needs immediate medical attention, because a sudden rise in eye pressure (angle-closure glaucoma) can cause permanent vision loss if untreated. High ammonia. Unexplained drowsiness, vomiting or confusion can be a sign of a raised ammonia level in the blood and should be reported to the prescriber.
People who have had an allergic reaction to sulfa drugs (sulfonamides) or to zonisamide should not take it. Some combinations add to zonisamide's specific risks. Topiramate (another seizure and migraine-prevention medicine) and acetazolamide (used for glaucoma and altitude sickness) block the same enzyme, so taking either with zonisamide can deepen the acid build-up and raise the risk of kidney stones and high ammonia levels. Valproic acid, a seizure and mood medicine, also raises the risk of high ammonia. A ketogenic diet, diarrhea, kidney disease or serious lung disease can add to the acid effect as well. Alcohol, sleep aids and other sedating medicines can add to drowsiness and slowed thinking. Some other seizure medicines, including phenytoin, carbamazepine and phenobarbital, speed up how quickly the body clears zonisamide. Starting, stopping or changing the dose of one of them can change zonisamide levels, so the prescriber may need to adjust the dose. Zonisamide did not change the hormone levels of a combined birth control pill in testing. Zonisamide may harm a developing baby: it caused birth defects in animal studies, and the acid build-up it causes may affect a pregnancy. The Zonisade label advises effective contraception during treatment and for one month after stopping. Anyone pregnant or planning pregnancy should talk with the prescriber early rather than stopping on their own, since uncontrolled seizures also carry risks. Zonisamide passes into breast milk, so a breastfed baby should be watched for poor feeding, weight loss, unusual sleepiness, floppiness or a raised temperature. Like all anti-seizure medicines, zonisamide carries a US Food and Drug Administration (FDA) warning that it can increase suicidal thoughts or behavior in a small number of people. New or worsening depression, unusual changes in mood or behavior, or thoughts of self-harm should be reported to the care team right away.
Because zonisamide is increased in steps and each step takes about two weeks to settle, it can take a couple of months to reach a dose that can be fairly judged. Keeping a seizure diary helps you and the prescriber see whether it is working. In the original three-month trials, people taking zonisamide typically saw their seizures fall by roughly a quarter to two-fifths, compared with little change on placebo, and about one in four had their seizures cut by three-quarters or more. For many people the realistic goal is fewer seizures rather than none. Sleepiness, dizziness and appetite changes are most noticeable after starting or raising the dose and often ease as the body adjusts. If side effects persist, a lower dose or a different medicine may suit better. Monitoring includes a blood test for bicarbonate before starting and from time to time during treatment, to check for the acid build-up. Zonisamide also tends to raise creatinine, a blood test of kidney function, by a small amount (about 8 percent on average in studies), an effect that stayed steady rather than worsening. If acid levels stay low, the prescriber may lower the dose, add a medicine to correct it or switch treatments. The trials that established its benefit lasted only a few months, so how well it keeps working is judged over time at follow-up visits. Any decision to stop, switch or reduce it is made with the prescriber and done gradually.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Zonisamide, what you've noticed, or ask the community a question.